drugset / Trial / NCT06758661

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

NCT06758661 ↗

Phase 1 Completed 40 enrolled Chong Kun Dang Pharmaceutical
NaCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, single arm, multi-dose, crossover study to evaluate drug-drug interaction and safety after co-administration of D352 and D794 in healthy adult volunteers.

Timeline

Start
2024-11-27
Primary completion
2025-01-24
Completion
2025-02-03

Drugs

EvaluationDrugModalityDoseRoute
Subject D352 Unknown — —
Subject D794 Unknown — —

Indications